Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer

The development of pancreatic cancer requires both, acquisition of an oncogenic mutation in KRAS as well as an inflammatory insult. However, the physiological causes for pancreatic inflammation are less defined. We show here that oncogenic KRas-expressing pre-neoplastic lesion cells upregulate coxsackievirus (CVB) and adenovirus receptor (CAR). This facilitates infections from enteroviruses such as CVB3, which can be detected in approximately 50% of pancreatic cancer patients. Moreover, using an animal model we show that a one-time pancreatic infection with CVB3 in control mice is transient, but in the presence of oncogenic KRas drives chronic inflammation and rapid development of pancreatic cancer. We further demonstrate that a knockout of CAR in pancreatic lesion cells blocks these CVB3-induced effects. Our data demonstrate that KRas-caused lesions promote the development of pancreatic cancer by enabling certain viral infections.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-12-04
DOI
https://doi.org/10.1038/s41467-024-55043-x
Citations
6
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
3.30

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer

Michael Anthony Hollingsworth, E. Aubrey Thompson, Heike Döppler, Brandy Edenfield et al.
6 citations
Nature Communications
Virus-based gene therapy research
3.30
article

Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer

Michael Anthony Hollingsworth, E. Aubrey Thompson, Heike Döppler, Brandy Edenfield, Alicia K. Fleming Martinez, Peter Störz, Ligia I. Bastea, DeLisa Fairweather, Veethika Pandey, Murli Krishna, Paul M. Grandgenett, Lizhi Zhang, Dahn L. Clemens, Xiang Liu
article en
6 citations

Abstract

The development of pancreatic cancer requires both, acquisition of an oncogenic mutation in KRAS as well as an inflammatory insult. However, the physiological causes for pancreatic inflammation are less defined. We show here that oncogenic KRas-expressing pre-neoplastic lesion cells upregulate coxsackievirus (CVB) and adenovirus receptor (CAR). This facilitates infections from enteroviruses such as CVB3, which can be detected in approximately 50% of pancreatic cancer patients. Moreover, using an animal model we show that a one-time pancreatic infection with CVB3 in control mice is transient, but in the presence of oncogenic KRas drives chronic inflammation and rapid development of pancreatic cancer. We further demonstrate that a knockout of CAR in pancreatic lesion cells blocks these CVB3-induced effects. Our data demonstrate that KRas-caused lesions promote the development of pancreatic cancer by enabling certain viral infections.

Nature CommunicationsVol. 15(1)
Jacksonville College (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US), University of Nebraska Medical Center (US)
National Institutes of Health, Center for Individualized Medicine, Mayo Clinic, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 7%
Virus-based gene therapy research
3.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.